American Portfolios Advisors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $66.9K | Buy |
2,985
+390
| +15% | +$8.74K | ﹤0.01% | 1553 |
|
|
2022
Q2 | $64.3K | Buy |
2,595
+870
| +50% | +$21.6K | ﹤0.01% | 1628 |
|
|
2022
Q1 | $66.9K | Buy |
1,725
+1,145
| +197% | +$44.4K | ﹤0.01% | 1739 |
|
|
2021
Q4 | $33.9K | Sell |
580
-75
| -11% | -$4.39K | ﹤0.01% | 2068 |
|
|
2021
Q3 | $38.8K | Buy |
655
+580
| +773% | +$34.4K | ﹤0.01% | 1915 |
|
|
2021
Q2 | $6.51K | Buy |
+75
| New | +$6.51K | ﹤0.01% | 2710 |
|
|
2020
Q4 | – | Sell |
-1,400
| Closed | -$56K | – | 3010 |
|
|
2020
Q3 | $56K | Buy |
1,400
+250
| +22% | +$9.99K | ﹤0.01% | 1282 |
|
|
2020
Q2 | $39.5K | Buy |
+1,150
| New | +$39.5K | ﹤0.01% | 1372 |
|